Marcus Shaker, MD

Marcus Shaker, MD, a professor of pediatrics and medicine at the Dartmouth Geisel School of Medicine

Articles by Marcus Shaker, MD

Early Introduction, Rescue Refeeding, and Home OIT: Reframing Pediatric Food Allergy Management

June 2nd 2026

At EAC 2026, Dartmouth Children's Health allergist Marcus Shaker, MD, outlined a framework built on shared decision-making for families navigating food allergy in infancy.

Early Allergen Introduction in Infants: Reducing Food Allergy Risk Without Routine Testing

ByMarcus Shaker, MD

June 1st 2026

Marcus Shaker, MD, discusses early allergen introduction, food allergy prevention, and the role of routine testing at EAC 2026.

Marcus Shaker, MD, MSc I Credit: Dartmouth Health

Anaphylaxis Treatment FAQ: When to Give Epinephrine, Order Tests, Call 911

ByMarcus Shaker, MD,Chelsie Derman

November 27th 2025

A quick guide for clinicians on epinephrine dosing, optimal observation periods, and the role of tryptase and other labs in anaphylaxis care.

Epinephrine Misconceptions Persist in Anaphylaxis Care, With Marcus Shaker, MD

ByMarcus Shaker, MD

November 7th 2025

At ACAAI 2025, Shaker dispels epinephrine myths, emphasizing that it is safe, effective, and underused in anaphylaxis care.

When to Prescribe Epinephrine for Known Anaphylaxis Triggers, With Marcus Shaker, MD

ByMarcus Shaker, MD

November 7th 2025

At ACAAI 2025, Shaker highlighted evolving therapies and real-world barriers that continue to limit optimal anaphylaxis management.

Marcus Shaker, MD

Articles by Marcus Shaker, MD

Early Introduction, Rescue Refeeding, and Home OIT: Reframing Pediatric Food Allergy Management

Early Allergen Introduction in Infants: Reducing Food Allergy Risk Without Routine Testing

Anaphylaxis Treatment FAQ: When to Give Epinephrine, Order Tests, Call 911

Epinephrine Misconceptions Persist in Anaphylaxis Care, With Marcus Shaker, MD

When to Prescribe Epinephrine for Known Anaphylaxis Triggers, With Marcus Shaker, MD

Latest Updated Articles

Trending on HCPLive

FDA Approves Olezarsen (Tryngolza) for Severe Hypertriglyceridemia

Delgocitinib Approval Fills a Long-Standing Gap in Chronic Hand Eczema Treatment

The Medical Sisterhood: The Strength Nobody Talks About, with Saakshi Khattri, MD

Q&A: Cardiometabolic Care Cascade Failure Points, with Rishi Wadhera, MD, MPP, MPhil

Q&A: CKM Care, IRA Policy, and Specialty Silos with Rishi Wadhera, MD, MPP, MPhil